We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+0.24%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.6B
AUM Growth
+$1.47B
Cap. Flow
+$1.6B
Cap. Flow %
9.12%
Top 10 Hldgs %
17.57%
Holding
1,695
New
602
Increased
310
Reduced
364
Closed
414

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$207M
2
PFE icon
Pfizer
PFE
+$171M
3
JNJ icon
Johnson & Johnson
JNJ
+$140M
4
SSNC icon
SS&C Technologies
SSNC
+$132M
5
MSFT icon
Microsoft
MSFT
+$131M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$158M
2
META icon
Meta Platforms (Facebook)
META
+$120M
3
BKNG icon
Booking.com
BKNG
+$106M
4
MRK icon
Merck
MRK
+$93.9M
5
IDXX icon
Idexx Laboratories
IDXX
+$92.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.54%
2 Technology 21.21%
3 Consumer Discretionary 13.38%
4 Industrials 12.45%
5 Financials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVRI
826
DELISTED
Everi Holdings
EVRI
$458K ﹤0.01%
+54,123
New +$554K
WCG
827
DELISTED
Wellcare Health Plans, Inc.
WCG
$457K ﹤0.01%
+1,765
New +$487K
FATE icon
828
Fate Therapeutics
FATE
$326M
$454K ﹤0.01%
+29,241
New +$561K
SAR icon
829
Saratoga Investment
SAR
$322M
$453K ﹤0.01%
+18,347
New +$453K
TBIO
830
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$451K ﹤0.01%
+45,472
New +$429K
BRC icon
831
Brady Corp
BRC
$4.57B
$445K ﹤0.01%
+8,377
New +$423K
NOA
832
North American Construction
NOA
$395M
$445K ﹤0.01%
38,635
+14,300
+59% +$164K
CSTL icon
833
Castle Biosciences
CSTL
$979M
$444K ﹤0.01%
+24,524
New +$544K
OVV icon
834
Ovintiv
OVV
$16.4B
$443K ﹤0.01%
19,251
-4,929
-20% -$113K
TAC icon
835
TransAlta
TAC
$3.93B
$437K ﹤0.01%
+67,173
New +$426K
EDU icon
836
New Oriental
EDU
$8.98B
$436K ﹤0.01%
+3,940
New +$412K
CNR
837
Core Natural Resources Inc
CNR
$4.45B
$433K ﹤0.01%
+27,639
New +$541K
BKD icon
838
Brookdale Senior Living
BKD
$3.4B
$418K ﹤0.01%
+55,161
New +$436K
TME icon
839
Tencent Music
TME
$15.6B
$412K ﹤0.01%
32,263
-41,141
-56% -$579K
ROP icon
840
Roper Technologies
ROP
$39.8B
$409K ﹤0.01%
1,149
+530
+86% +$192K
DSGX icon
841
Descartes Systems
DSGX
$6.82B
$405K ﹤0.01%
+10,029
New +$371K
KSS icon
842
Kohl's
KSS
$2.19B
$399K ﹤0.01%
+8,034
New +$394K
SNA icon
843
Snap-on
SNA
$21.5B
$398K ﹤0.01%
+2,545
New +$391K
CVNA icon
844
Carvana
CVNA
$77.9B
$396K ﹤0.01%
29,975
-33,495
-53% -$481K
AVT icon
845
Avnet
AVT
$7.92B
$394K ﹤0.01%
+8,851
New +$382K
MIDD icon
846
Middleby
MIDD
$6.08B
$394K ﹤0.01%
+3,368
New +$413K
AAON icon
847
Aaon
AAON
$7.77B
$388K ﹤0.01%
+12,665
New +$409K
HCAT icon
848
Health Catalyst
HCAT
$128M
$388K ﹤0.01%
+12,268
New +$483K
STAG icon
849
STAG Industrial
STAG
$7.19B
$387K ﹤0.01%
+13,098
New +$389K
FTS icon
850
Fortis
FTS
$28.7B
$385K ﹤0.01%
9,100
+900
+11% +$36.7K
32 33
34
35 36

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2019 Portfolio in Review

As of Q3 2019, Marshall Wace North America held 1,695 positions worth $17.6B, up 9.1% from $16.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $1.6B of net new capital in Q3 2019, opening 602 new positions and adding to 310 existing holdings. Its largest new stake was Johnson & Johnson: 1,065,531 shares worth $138M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $120M trimmed.

  • Marshall Wace North America's largest Q3 2019 buy was Johnson & Johnson: 1,065,531 shares worth $138M.
  • Marshall Wace North America added most to Apple in Q3 2019, an estimated $207M increase.
  • Marshall Wace North America's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $120M.
  • Marshall Wace North America fully exited Abbott in Q3 2019, selling an estimated $158M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $17.6B portfolio in Q3 2019.
  • Marshall Wace North America opened 602 new positions and closed 414 in Q3 2019.
  • Marshall Wace North America's portfolio value rose 9.1% quarter-over-quarter to $17.6B.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.